History and future of critical care pharmacy practice

American Journal of Health-System Pharmacy

Volumn 72, Issue 23, 2015, Pages 2101-2105

  Benedict, Neal ^a   Hess, Mary M ^b  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; ADVERSE DRUG REACTION; ANTICOAGULANT THERAPY; ANTIMICROBIAL THERAPY; ARTIFICIAL VENTILATION; CALCULATION; CERTIFICATION; CLINICAL PHARMACY; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL RESEARCH; CRITICALLY ILL PATIENT; CURRICULUM; DISEASE SEVERITY; DRUG DISTRIBUTION; DRUG INFORMATION; DRUG MONITORING; DRUG RESEARCH; DRUG THERAPY; DRUG USE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HISTORY OF MEDICINE; HOSPITAL COST; HOSPITAL PHARMACY; HUMAN; INTENSIVE CARE; LEADERSHIP; LENGTH OF STAY; MEDICAL EDUCATION; MEDICAL SOCIETY; MEDICATION ERROR; MORTALITY RATE; NOTE; PARAMEDICAL EDUCATION; PARENTERAL NUTRITION; PARTIAL THROMBOPLASTIN TIME; PATIENT CARE; PATIENT SAFETY; PHARMACEUTICAL CARE; PHARMACIST ATTITUDE; PHARMACOKINETICS; POSTGRADUATE EDUCATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; QUALITY CONTROL; RISK REDUCTION; SCOPE OF PRACTICE; SEDATION; STANDARD; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; ORGANIZATION AND MANAGEMENT; PHARMACIST; PROFESSIONAL STANDARD; SPECIALIZATION; TRENDS;

CRITICAL CARE; HUMANS; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE; SPECIALIZATION;

EID: 84962900961     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp150638     Document Type: Note

References (48)

1. Elenbaas RM, Worthen DB. Clinical pharmacy in the United States. Lenexa, KS: American College of Clinical Pharmacy; 2009.
2. Day RL, Goyan JE, Herfindal ET et al. The origins of the clinical pharmacy program at the University of California, San Francisco. Drug Intell Clin Pharm. 1991; 25:308-14.
3. American Society of Health-System Pharmacists. History of residency training. www.ashp.org/menu/PracticePolicy/ResourceCenters/Residency/General-Information/ResidencyHistory.aspx (accessed 2015 Aug 5).
4. American Society of Hospital Pharmacists. Supplemental standard and learning objectives for residency training in critical-care pharmacy practice. Am J Hosp Pharm. 1990; 47:609-12.
5. American Society of Health-System Pharmacists. Educational outcomes, goals, and objectives for postgraduate year two (PGY2) pharmacy residencies in critical care. www.ashp.org/DocLibrary/Accreditation/Regulations-standards/RTPObjCriticalCare032608.pdf (accessed 2015 Jul 7).
6. American Society of Health-System Pharmacists. Online residency directory. http://accred.ashp.org/aps/pages/directory/residencyProgramSearch.aspx#1 (accessed 2015 Jul 7).
7. Sawchuck RJ, Zaske DE. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients. J Pharm Biopharm. 1976; 4:183-95.
8. Weil MH, Tang W. From intensive care to critical care medicine. Am J Respir Crit Care Med. 2011; 183:1451-3.
9. Weil MH, Shoemaker WC. Pioneering contributions of Peter Safar to intensive care and the founding of the Society of Critical Care Medicine. Crit Care Med. 2004; 32(suppl 2):S8-10.
10. Society of Critical Care Medicine. About SCCM. www.sccm.org/About-SCCM/Pages/default.aspx (accessed 2015 Aug 8).
11. Kaul AF, Johnson EG, Powell SH. Postgraduate pharmacy fellowships (1987-1988). Drug Intell Clin Pharm. 1988; 22:168-72.
12. American College of Clinical Pharmacy. ACCP guidelines for clinical research fellowship training programs. www.accp.com/docs/positions/guidelines/pos15.pdf (accessed 2015 Jul 7).
13. American Society of Health-System Pharmacists Research and Education Foundation. ASHP Foundation critical care traineeship: application policies and guidelines. http://ashpfoundationapply.org/docs/resources/Critical%20Care%20 Application%20Instructions-06-24-15.pdf (accessed 2015 Aug 6).
14. Montazeri M, Cood DJ. Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Crit Care Med. 1994; 22:1044-8.
15. Presalaski CR, Lat I, MacLaren R et al. Pharmacist contributors as members of the multidisciplinary ICU team. Chest. 2013; 144:1687-95.
16. Leape LL, Cullen DJ, Clapp MD et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999; 282:267-70.
17. Ng TM, Bell AM, Hong C et al. Pharmacist monitoring of QTc intervalprolonging medications in critically ill medical patients: a pilot study. Ann Pharmacother. 2008; 42:475-82.
18. Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy. 2007; 27:481-93.
19. Devlin JW, Holbrook AM, Fuller HD. The effect of ICU sedation guidelines and pharmacist interventions on clinical outcomes and drug cost. Ann Pharmacother. 1997; 31:689-95.
20. Skledar SJ, Hess MM. Implementation of a drug-use and disease state management program. Am J Health-Syst Pharm. 2000; 57(suppl 4):S23-9.
21. MacLaren R, Bond CA, Martin SJ et al. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med. 2008; 36:3184-9.
22. Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy. 1999; 19:556-64.
23. American College of Clinical Pharmacy. Critical Care PRN history 1992-2015. www.accp.com/docs/prns/history/crit.pdf (accessed 2015 Aug 1).
24. Rudis MI, Brandl KM. Position paper on critical care pharmacy services. Crit Care Med. 2000; 28:3746-50.
25. Brilli RJ, Spevitz A, Branson RD et al. Critical care delivery in the intensive care unit: defining clinical roles and the best practice model. Crit Care Med. 2001; 29:2007-19.
26. Haupt MT, Bekes CE, Brilli RJ et al. Guidelines on critical care services and personnel: recommendations based on a system of categorization of three levels of care. Crit Care Med. 2003; 31:2677-83.
27. MacLaren R, Devlin JW, Martin SJ et al. Critical care pharmacy services in United States hospitals. Ann Pharmacother. 2006; 40:612-8.
28. Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy. 2007; 27:481-93.
29. MacLaren R, Brett McQueen R, Campbell J. Clinical and financial impact of pharmacy services in the intensive care unit: pharmacist and prescriber perceptions. Pharmacotherapy. 2013; 33:401-10.
30. Kim MM, Barnato AE, Angus DC et al. The effect of multidisciplinary care teams on intensive care unit mortality. Arch Intern Med. 2010; 170:369-76.
31. MacLaren R, Bond CA, Martin SJ, Fike D. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med. 2008; 36:3184-9.
32. MacLaren R, Bond CA. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events. Pharmacotherapy. 2009; 29:761-8.
33. Netzer G, Liu X, Shanholtz C et al. Decreased mortality resulting from a multicomponent intervention in a tertiary care medical intensive care unit. Crit Care Med. 2011; 39:284-93.
34. Weant KA, Armistead JA, Ladha AM et al. Cost effectiveness of a clinical pharmacist on a neurosurgical team. Neurosurgery. 2009; 5:946-50.
35. Carver PL, Lin SW, DePestel DD, Newton DW. Impact of mecA gene testing and intervention by infectious disease clinical pharmacists on time to optimal antimicrobial therapy for Staphylococcus aureus bacteremia at a university hospital. J Clin Microbiol. 2008; 46:2381-3.
36. Gentry CA, Greenfield RA, Slater LN et al. Outcomes of an antimicrobial control program in a teaching hospital. Am J Health-Syst Pharm. 2000; 57:268-74.
37. Petitta A. Assessing the value of pharmacists' health-systemwide services: clinical pathways and treatment guidelines. Pharmacotherapy. 2000; 20(10, pt. 2):327S-332S.
38. To L, Schillig JM, Desmet BD et al. Impact of a pharmacist-directed anticoagulation service on the quality and safety of heparin-induced thrombocytopenia management. Ann Pharmacother. 2011; 45:195-200.
39. Dager W, Bolesta S, Brophy G et al. An opinion paper outlining recommendations for training, credentialing, and documenting and justifying critical care pharmacy services. Pharmacotherapy. 2011; 31:135e-175e.
40. MacLaren R, Plamondon J, Ramsay K et al. A prospective evaluation of empiric versus protocol based sedation and analgesia. Pharmacotherapy. 2000; 20:662-72.
41. Marshall J, Finn CA, Theodore AC. Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med. 2008; 36:427-33.
42. National Matching Services Inc. Summary of programs and positions offered and filled for the 2015 Match. www.natmatch.com/ashprmp/state/2015summpos.html (accessed 2015 Mar 27).
43. American College of Clinical Pharmacy. Petition to the Board of Pharmacy Specialties requesting recognition of critical care pharmacy practice as a specialty. www.accp.com/docs/positions/petitions/Final-CRITICAL-CARE-PETITION-For-BPS-Post.pdf (accessed 2015 Jul 21).
44. Board of Pharmacy Specialties. Specialties: critical care pharmacy. www.bpsweb.org/specialties/criticalcarepharmacy.cfm (accessed 2015 Jul 23).
45. American College of Clinical Pharmacy position statement: board certification of pharmacist specialists. Pharmacotherapy. 2011; 31:1146-9.
46. Dasta JF, Segal R, Cunningham A. A national survey of critical care pharmaceutical services. Am J Hosp Pharm. 1989; 46:2308-12.
47. Randolph AG, Pronovost P. Reorganizing the delivery of intensive care could improve efficiency and save lives. J Eval Clin Pract. 2002; 8:1-8.
48. Shojania K, Duncan B, McDonald K, Wachter RM, for Agency for Healthcare Research and Quality. Making health care safer: a critical analysis of patient safety practices (July 20, 2001). http://archive. ahrq.gov/clinic/ptsafety/pdf/ptsafety.pdf (accessed 2015 Aug 31).